Zenex Animal Health has finalized the acquisition of Ayurvet, a distinguished provider of ayurvedic and herbal solutions catering to animal health. This strategic move aligns with Zenex's overarching vision to extend animal health solutions on a global scale.

Founded by Pradip Burman, Ayurvet specializes in offering natural medicines, feed supplements, and topical treatments tailored for animals. The acquisition by Zenex Animal Health is anticipated to fortify its animal health portfolio significantly. The addition of Ayurvet's renowned ayurvedic and herbal products is poised to complement and enhance Zenex's existing capabilities in the animal health sector.

Zenex, backed by investors spearheaded by Multiples PE and encompassing notable entities like CPP Investments, RARE Enterprises, SBI, ADB, IFC, and HNIs, views this acquisition as a catalyst for its growth trajectory, particularly within a mutually supportive sector.

Dr. Arun Atrey, MD and CEO of Zenex, emphasized how the acquisition amplifies Zenex's expansion, highlighting the synergies prevalent in the overlapping spheres of operation.

Renuka Ramnath, Chairperson at Zenex, regarded this acquisition as a pivotal milestone in bolstering the company's product offerings and reaffirming its leadership position within the industry.

Expressing confidence in the future trajectory, Pradip Burman, Founder of Ayurvet, underscored his belief in Zenex's management to propel Ayurvet's vision forward, ensuring the continued legacy and advancement of its objectives.

The acquisition between Zenex Animal Health and Ayurvet symbolizes a concerted effort to combine expertise and innovation in the field of herbal animal solutions. This strategic collaboration is poised to carve new dimensions in the global animal health sector, leveraging Ayurvet's herbal expertise and Zenex's robust industry presence to cater to evolving market demands and animal wellness needs.